Abstract:Background: Dysregulated ubiquitination may contribute to the inflammation process in ulcerative colitis (UC). Genome-wide association studies indicate the association between ubiquitin-specific peptidases 3 (USP3) and UC. This study investigated the role of USP3 in macrophage activation in UC. Methods: The relative USP3 expression was assayed in the peripheral blood mononuclear cells (PBMCs) derived from UC patients and healthy volunteers or bone marrow-derived macrophages (BMDMs) stimulated with lipopolysaccharide (LPS). Myeloid cell-conditional USP3 transgenic (USP3-Tg) mice and wild type mice were treated with 3% dextran sulfate sodium for five successive days to induce colitis, and the relevant pro-inflammatory cytokines were detected in LPS or cytosine guanosine dinucleotide (CpG) stimulated BMDMs. Results: Down-regulated USP3 was observed in UC patients (p < 0.005) and LPS stimulated BMDMs (p < 0.05). USP3-Tg mice demonstrated alleviated colitis symptoms, including less weight loss (all p < 0.05 from day 2), better survival (p < 0.01), lower intestinal bleeding (all p < 0.05 from day 4), and longer large intestine length (p < 0.05). On the other hand, diminished nitric oxide synthase 2 (NOS2) (p < 0.05), interleukin (IL)-6 (p < 0.01), and tumor necrosis factor (TNF) expression (p < 0.05) were detected in USP3-Tg mice. Mechanically, USP3 directly bound with transforming growth factor beta-activated kinase 1 (TAK1) to deubiquitinate TAK1 and inhibited downstream nuclear factor kappa-B (NF-kappa B) and mitogen-activated protein kinase signals. Conclusions: USP3 can function as deubiquitinase to promote the activation of TAK1 in macrophages to impair the inflammatory responses in colitis.

Deubiquitinase USP3 in Macrophages Impaires the Inflammatory Responses in the Colitis Model